These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 4195933)

  • 21. [The erythrocytic ALA-dehydratase test in lead poisoning].
    Bonsignore D
    Med Lav; 1973; 64(7):264-7. PubMed ID: 4790627
    [No Abstract]   [Full Text] [Related]  

  • 22. Erythrocyte delta-aminolevulinic acid dehydratase activity as a measure of lead exposure.
    Morgan JM; Burch HB
    J Lab Clin Med; 1975 May; 85(5):746-55. PubMed ID: 235593
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Experimental and human lead poisoning. Inhibitory mechanism of erythrocyte ALA-dehydratase].
    Bonsignore D; Cartasegna C; Vergnano C; Ardoino V
    Med Lav; 1968; 59(6):419-24. PubMed ID: 5738987
    [No Abstract]   [Full Text] [Related]  

  • 24. delta-Aminolaevulinic acid dehydratase as an index of lead toxicity. Time for a reappraisal?
    Chalevelakis G; Bouronikou H; Yalouris AG; Economopoulos T; Athanaselis S; Raptis S
    Eur J Clin Invest; 1995 Jan; 25(1):53-8. PubMed ID: 7705388
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Experimental studies on porphyrin metabolism in various heavy metal poisoning. (II). Effect of lead, mercury and arsenic compounds on delta-aminolevulinic dehydratase activity (author's transl)].
    Murai C
    Nihon Eiseigaku Zasshi; 1975 Jun; 30(2):337-45. PubMed ID: 1237679
    [No Abstract]   [Full Text] [Related]  

  • 26. [Erythrocytic ALA-dehydratase activity in subjects not occupationally exposed to lead, living in rural and urban areas].
    Secchi GC; Alessio L; Cambiaghi G
    Quad Sclavo Diagn; 1972 Mar; 8(1):468-84. PubMed ID: 4123509
    [No Abstract]   [Full Text] [Related]  

  • 27. Detection of lead toxicity.
    Clark JL
    N Engl J Med; 1971 Sep; 285(11):636. PubMed ID: 5563969
    [No Abstract]   [Full Text] [Related]  

  • 28. The neurobehavioral effects of early lead exposure.
    Dietrich KN; Krafft KM; Shukla R; Bornschein RL; Succop PA
    Monogr Am Assoc Ment Defic (1982); 1987; (8):71-95. PubMed ID: 3614268
    [No Abstract]   [Full Text] [Related]  

  • 29. Effect of lead on -aminolevulinic acid dehydrase activity in red blood cells.
    Haeger-Aronsen B; Abdulla M; Fristedt BI
    Arch Environ Health; 1971 Dec; 23(6):440-5. PubMed ID: 4109097
    [No Abstract]   [Full Text] [Related]  

  • 30. Effect of vitamin E on delta-aminolevulinic acid dehydratase activity in weanling rabbits with chronic plumbism.
    Bartlett RS; Rousseau JE; Frier HI; Hall RC
    J Nutr; 1974 Dec; 104(12):1637-45. PubMed ID: 4430935
    [No Abstract]   [Full Text] [Related]  

  • 31. Undue absorption of lead among children--a new look at an old problem.
    Lin-Fu JS
    N Engl J Med; 1972 Mar; 286(13):702-10. PubMed ID: 4551386
    [No Abstract]   [Full Text] [Related]  

  • 32. Lead as a cause of mental retardation.
    Med J Aust; 1977 May; 1(21):766. PubMed ID: 875854
    [No Abstract]   [Full Text] [Related]  

  • 33. [Erythrocyte ALA-dehydratase and exposure to lead in workers in a glass factory].
    Franzinelli A; Battista G; Benelli A; Sartorelli E
    Med Lav; 1974; 65(5-6):206-14. PubMed ID: 4456168
    [No Abstract]   [Full Text] [Related]  

  • 34. Role of chronic low-level lead exposure in the aetiology of mental retardation.
    Beattie AD; Moore MR; Goldberg ; Finlayson MJ; Graham JF; Mackie EM; Main JC; McLaren DA; Murdoch KM; Steward GT
    Lancet; 1975 Mar; 1(7907):589-92. PubMed ID: 47943
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lead colic masquerading as intestinal obstruction.
    Esham RH; Sugg JH
    South Med J; 1973 Aug; 66(8):959-60. PubMed ID: 4721071
    [No Abstract]   [Full Text] [Related]  

  • 36. Evaluation of lead levels in biological samples of mentally retarded children in different stages using advanced extraction method.
    Kazi TG; Shah F; Afridi HI; Mughal MA; Naeemullah ; Arain SS; Arain MB
    Environ Toxicol Pharmacol; 2013 Nov; 36(3):858-64. PubMed ID: 23981376
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Blood lead levels in normal and mentally deficiency children.
    Gibson SL; Lam CN; McCrae WM; Goldberg A
    Arch Dis Child; 1967 Dec; 42(226):573-8. PubMed ID: 4229264
    [No Abstract]   [Full Text] [Related]  

  • 38. Screening techniques for undue lead exposure in children: biological and practical considerations.
    Chisolm JJ
    J Pediatr; 1971 Nov; 79(5):719-25. PubMed ID: 4941955
    [No Abstract]   [Full Text] [Related]  

  • 39. Increased blood lead levels in mentally retarded children in Greece.
    Youroukos S; Lyberatos C; Philippidou A; Gardikas C; Tsomi A
    Arch Environ Health; 1978; 33(6):297-300. PubMed ID: 736612
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Assays for porphyrins, delta-aminolevulinic-acid dehydratase, and porphyrinogen synthetase in microliter samples of whole blood: applications to metabolic defects involving the heme pathway.
    Granick S; Sassa S; Granick JL; Levere RD; Kappas A
    Proc Natl Acad Sci U S A; 1972 Sep; 69(9):2381-5. PubMed ID: 4506758
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.